Evidence map›Paper›PMID 26106213›Full record

ArticleRheumatology (Oxford, England)2015

Coronary calcification in SLE: comparison with the Multi-Ethnic Study of Atherosclerosis.

Adnan N Kiani, Laurence S Magder, Wendy S Post, Moyses Szklo, Joan M Bathon, Pam J Schreiner, Daniel O'Leary, Michelle Petri

Abstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. The Pathophysiology of Coronary Artery Disease.The International journal of angiology : official publication of the International College of Angiology, Inc · 2025
    Review
  5. Cardiac Involvement in Systemic Lupus Erythematosus.Reviews in cardiovascular medicine · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Atherosclerosis in Systemic Lupus Erythematosus.Current atherosclerosis reports · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Chronic rheumatologic disorders and cardiovascular disease risk in women.American heart journal plus : cardiology research and practice · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Cardiovascular disease in systemic lupus erythematosus.Rheumatology and immunology research · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adnan N KianiDepartment of Medicine, Division of Rheumatology, Johns Hopkins University.
Laurence S MagderDepartment of Epidemiology and Preventive Medicine, University of Maryland.
Wendy S PostDepartment of Medicine, Division of Rheumatology, Johns Hopkins University.
Moyses SzkloDepartment of Epidemiology, School of Medicine and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.
Joan M BathonDepartment of Medicine, Division of Rheumatology, Johns Hopkins University.
Pam J SchreinerDepartment of Epidemiology, Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, MN and.
Daniel O'LearyDepartment of Medicine, Tufts University School of Medicine, Boston, MA, USA.
Michelle PetriDepartment of Medicine, Division of Rheumatology, Johns Hopkins University, mpetri@jhmi.edu.

Funding

Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
University of Maryland Claude D. Pepper Older Americans Independence Center (UM-OAIC)P30AG028747 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI ALICE S. RYAN · 2006 to 2026
$28.9M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
Lupus CohortR01AR043727 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 1997 to 2015
$8.2M
SUBCLINICAL CARDIOVASCULAR DISEASE STUDY-FIELD CENTERN01HC095162 · HC · JOHNS HOPKINS UNIVERSITY · PI SZKLO, MOYSES A · 1999 to 2000
$694k
HOPKINS LUPUS COHORTR55AR043727 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 1996 to 1996
–
NCATS NIH HHS UL1 TR000040NCATS NIH HHS UL1-TR-000040NCATS NIH HHS UL1 TR001079NCATS NIH HHS UL1-TR-001079NCRR NIH HHS UL1 RR 025005NCRR NIH HHS UL1 RR025005NHLBI NIH HHS N01 HC095162NHLBI NIH HHS N01-HC-95162NIAMS NIH HHS AR43727NIAMS NIH HHS R01 AR043727NIA NIH HHS P30 AG028747
6 · The paper itself

Abstract

objectiveAccelerated atherosclerosis is a major cause of morbidity and death in SLE. The purpose of this study was to determine whether the prevalence and extent of coronary artery calcium (CAC) is higher in female SLE patients compared with a non-SLE sample from the Multi-Ethnic Study of Atherosclerosis (MESA).

methodsCAC was measured in 80 female SLE patients and 241 female MESA controls from the Baltimore Field Centre, ages 45-64 years, without evidence of clinical cardiovascular disease. Binary regression was used to estimate the ratio of CAC prevalence in SLE vs MESA controls, controlling for demographic and cardiovascular risk factors. To compare the groups with respect to the quantity of CAC among those with non-zero Agatston scores, we used linear models in which the outcome was a log-transformed Agatston score.

resultsThe prevalence of CAC was substantially higher in SLE. The differences were most pronounced and statistically significant in those aged 45-54 years (58% vs 20%, P < 0.0001), but were still observed among those aged 55-65 years (57% vs 36%, P = 0.069). After controlling for age, ethnicity, education, income, diabetes mellitus, hypertension, hyperlipidaemia, high-density lipoprotein levels, smoking, education and BMI, SLE patients still had a significantly higher prevalence of CAC than controls. Among those with CAC, the mean log Agatston score did not differ significantly between SLE and MESA participants.

conclusionWomen with SLE have a higher prevalence of CAC than comparable women without SLE, even after adjusting for traditional cardiovascular risk factors, especially among those aged 45-54 years.

Indexed as

Age FactorsAtherosclerosisBlack or African AmericanCalcinosisCalciumCase-Control StudiesCoronary VesselsEthnicityFemaleHumansLupus Erythematosus, SystemicMiddle AgedPrevalenceRisk FactorsTomography, Spiral ComputedWhite PeopleCalciumAgatston scoreatherosclerosiscardiovascularcohortcomputed tomographycoronary artery calciuminflammationMESAstatinssystemic lupus erythematosus

Identifiers

PMID26106213
PMCPMC4715250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.